文献速递眼底病与葡萄膜炎

葡萄膜炎患者血清修饰核苷酸的标志性特征

The Signature of Serum Modified Nucleosides in Uveitis.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

本研究采用液相色谱-串联质谱(LC-MS)定量42例不同亚型葡萄膜炎患者(特发性葡萄膜炎、Vogt-小柳-原田病、强直性脊柱炎)及32例健康对照血清中23种修饰核苷浓度,发现13种可定量,m2G、Gm、Cm、m1G在健康对照与葡萄膜炎患者间有极显著差异,Gm、m6A、m5U可进一步区分特发性葡萄膜炎与伴全身炎症的葡萄膜炎(VKH和AS)。

要点

  • 42例葡萄膜炎患者与32例健康对照的血清中13/23种修饰核苷可定量检测。
  • m2G、Gm、Cm、m1G在健康对照与葡萄膜炎患者间差异极显著。
  • Gm、m6A、m5U可区分特发性葡萄膜炎与VKH/AS相关葡萄膜炎。

核心结论

  • 葡萄膜炎患者血清修饰核苷代谢与健康对照存在显著差异,各亚型具有特征性血清修饰核苷组合,可能用于葡萄膜炎的潜在诊断。

研究设计与样本

  • 回顾性病例对照研究,纳入42例不同亚型葡萄膜炎患者(特发性葡萄膜炎、Vogt-小柳-原田病、强直性脊柱炎)和32例健康对照,采用液相色谱-串联质谱(LC-MS)定量血清中23种修饰核苷。

主要发现

  • 23种修饰核苷中13种(m6A、m1A、m6Am、Cm、ac4C、Gm、m1G、m2G、m2,2G、Um、m3U、m5U、m5Um)显示可定量色谱峰。
  • 健康对照与葡萄膜炎患者间m2G、Gm、Cm、m1G差异极显著。
  • Gm、m6A、m5U的差异可进一步区分特发性葡萄膜炎与伴全身炎症的葡萄膜炎(包括VKH和AS)。
  • 与健康对照相比,每种葡萄膜炎亚型均有其特征性血清修饰核苷组合。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aims to evaluate the metabolism of serum-modified nucleosides in uveitis by using liquid chromatography-tandem mass spectrometry (LC-MS) and to develop potential diagnostic biomarkers for uveitis. METHODS: Forty-two patients with different subtypes of uveitis (idiopathic uveitis, Vogt-Koyanagi-Harada [VKH] disease, and ankylosing spondylitis [AS]) and 32 healthy controls were recruited in this retrospective case-control study. The concentrations of 23 modified nucleosides in patient serum were quantified by LC-MS. The data was statistically analyzed with SPSS and GraphPad Prism. RESULTS: The data revealed that 13 out of 23 modified nucleosides (m6A, m1A, m6Am, Cm, ac4C, Gm, m1G, m2G, m2,2G, Um, m3U, m5U, and m5Um) effectively showed quantifiable chromatographic peaks. The statistical results indicated that there were extremely significant differences for m2G, Gm, Cm, and m1G between healthy controls and uveitis patients. The differences for Gm, m6A,and m5U were able to further assort idiopathic uveitis and uveitis with systemic inflammation including VKH and AS. Interestingly, each specific subtype of uveitis is characterized by its signature combination of serum-modified nucleotides comparing with healthy controls. CONCLUSIONS: This study revealed that the metabolism of serum-modified nucleosides in uveitis patients display significant differences from healthy controls. The signature combination of serum modified nucleotides for each subtype of uveitis may be applied for the potential diagnosis of uveitis.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Zhou H, Hu Y, Qin G, et al. The Signature of Serum Modified Nucleosides in Uveitis. Invest Ophthalmol Vis Sci. 2025. PMID: 40014362. doi:10.1167/iovs.66.2.68

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。